Fertility preservation in women with peritoneal surface malignancies: A case series.

Cytoreductive surgery Fertility preservation Hyperthermic intraperitoneal chemotherapy Infertility Oocyte Primary peritoneal disease

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
11 2021
Historique:
received: 12 01 2021
revised: 23 03 2021
accepted: 28 03 2021
pubmed: 18 4 2021
medline: 6 1 2022
entrez: 17 4 2021
Statut: ppublish

Résumé

The advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has improved survival in patients with peritoneal surface malignancies. Not surprisingly, there is now a growing interest on the possible means to preserve fertility to ensure future childbearing. In this study, we report on five women with peritoneal surface malignancies who performed ovarian hyper-stimulation and oocytes cryostorage prior to undergo CRS and HIPEC. The presence of the disease complicated follicular growth monitoring but the oocytes retrievals could be always performed and were uneventful. At last follow-up, all women were alive and disease-free. None has yet returned to thaw her oocytes. Overall, these cases suggest that oocytes cryopreservation before CRS and HIPEC should be considered.

Identifiants

pubmed: 33863607
pii: S0748-7983(21)00404-2
doi: 10.1016/j.ejso.2021.03.259
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2948-2951

Informations de copyright

Copyright © 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Edgardo Somigliana reports grants from Ferring, grants and personal fees from Merck, grants and personal fees from Theramex, outside the submitted work. All the other authors do not have any conflict of interest to declare.

Auteurs

Francesca Filippi (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: francesca.filippi@policlinico.mi.it.

Shigeki Kusamura (S)

IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Fabio Martinelli (F)

IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Edgardo Somigliana (E)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Community and Clinical Sciences, University of Milan, Milan, Italy. Electronic address: dadosomigliana@yahoo.it.

Marcello Deraco (M)

IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH